4.11.1.1Vertical
Point-of-Care Veterinary Diagnostics
In-clinic rapid diagnostic testing devices for veterinary practices.
Market snapshot
These figures describe Animal Diagnostics & Laboratory (4.11.1), the segment that Point-of-Care Veterinary Diagnostics sits within — not Point-of-Care Veterinary Diagnostics on its own.
FragmentationConsolidatedEstimate
Within veterinary services (NAICS 541940) and medical laboratories; the Census Bureau does not separate veterinary diagnostics, so the segment is not separately sized here.
Business model & economics
Revenue model
Reference-lab testing plus in-clinic analyzer-and-consumable sales
Key economics
- Recurring revenue
- High
- EBITDA margin
- Strong
- Capex intensity
- High
recurring testing and consumables
razor-and-blade diagnostics economics
Characteristics
- High-margin duopoly (IDEXX, Antech) plus Zoetis.
- Reference labs plus in-clinic point-of-care diagnostics.
- Pet humanization and rising utilization drive growth.
M&A deal context
Deal activityHigh
Who’s acquiring
- Veterinary-diagnostics majors
- Animal-health strategics
- PE-backed lab platforms
What’s driving deals
- Recurring, high-margin diagnostics economics.
- Pet-humanization-driven utilization.
- Point-of-care and reference-lab consolidation.
Find Point-of-Care Veterinary Diagnostics acquisition targets
Search Acquisera’s index for companies classified under Point-of-Care Veterinary Diagnostics (4.11.1.1) and build a targeted deal pipeline.
Search companies